SHANGHAI--(BUSINESS WIRE)--ShangPharma Corporation (NYSE:SHP) ("ShangPharma" or “the Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will be meeting investors at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco from January 10 to 13, 2011.
